Overview A Study to Evaluate the Pharmacokinetics and Safety of LY03003 in Patients With Advanced-stage PD Status: Recruiting Trial end date: 2021-07-31 Target enrollment: Participant gender: Summary This study is to evaluate the pharmacokinetics and safety of LY03003 in patients with advanced-stage PD. Phase: Phase 1 Details Lead Sponsor: Luye Pharma Group Ltd.